Confined placental mosaicism: Distribution of chromosomally abnormal cells over the term placenta

Non-invasive prenatal testing (NIPT) investigates placental DNA and may detect confined placental mosaicism (CPM). The aim of this study was to confirm CPM in the term placenta in cases with abnormal NIPT but normal follow-up cytogenetic studies of fetus and mother. Additionally we examined the dist...

Full description

Saved in:
Bibliographic Details
Published inPlacenta (Eastbourne) Vol. 154; pp. 60 - 65
Main Authors Eggenhuizen, G.M., van Veen, S., van Koetsveld, N., Go, A.T.J.I., Diderich, K.E.M., Joosten, M., van den Born, M., Srebniak, M.I., Van Opstal, D.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 02.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Non-invasive prenatal testing (NIPT) investigates placental DNA and may detect confined placental mosaicism (CPM). The aim of this study was to confirm CPM in the term placenta in cases with abnormal NIPT but normal follow-up cytogenetic studies of fetus and mother. Additionally we examined the distribution of abnormal cells over the placenta. Four chorionic villus (CV) biopsies from four placental quadrants were requested in cases where CPM was assumed. Both cell lineages of the CV, cytotrophoblast (CTB) and mesenchymal core (MC), were analyzed separately with SNP array. The chromosome aberration was confirmed in 67 % of the placentas. Three quarters of the CTB and MC biopsies from these mosaic placentas were uniformly normal (57 %) or abnormal (20 %), and a minority showed mosaicism. Among 16 cases of CPM where first trimester CV were examined as well, 11 had chromosomally normal results during pregnancy. Cytogenetic investigations of term placental biopsies suspected to be affected with CPM did not reveal the chromosome aberration in one third of the placentas. This is caused by the patchy pattern in which chromosomally abnormal cells are distributed over the placenta with the majority of the biopsies being uniformly normal. Further CPM research, including its clinical impact, requires the analysis of more than four biopsies to get insight into the extent of the affected part. Moreover, a subset of CPM type 1 and 3 seems to be only detectable with NIPT and not with first trimester CVS. •Confirming confined placental mosaicism (CPM) in term placentas is challenging.•CPM exhibits a patchy pattern over the placenta with most biopsies uniformly normal.•A subset of CPM type 1 and 3 seems to be only detectable with NIPT and not with CVS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0143-4004
1532-3102
1532-3102
DOI:10.1016/j.placenta.2024.06.008